AGIO Agios Pharmaceuticals, Inc.
31.79USD+0.22%Mkt Cap: 1.90B $P/E: —1d ago
Agios Pharmaceuticals, Inc., a biopharmaceutical company, discovers and develops medicines in the field of cellular metabolism in the United States. Its lead product includes PYRUKYND (mitapivat), an activator of wild-ty…
Industry Peers
Biotechnology$128.08BUSDP/E 29.4
$78.44BUSD
$76.40BUSDP/E 18.4
$57.03BUSDP/E 37.3
$58.08BUSDP/E 35.4
$42.24BUSDP/E 18.0
$43.05BUSD
$41.41BUSDP/E 65.1
$32.80BUSDP/E 30.2
$30.03BUSDP/E 37.8
$25.10BUSD
$23.93BUSD
$22.99BUSDP/E 14.5
$22.27BUSDP/E 30.7
$22.54BUSDP/E 28.9
$22.22BUSD
$15.03BUSDP/E 17.5
$15.01BUSDP/E 15.8
$14.48BUSDP/E 18.4
$14.32BUSD
Key Statistics
Company
Market Cap1.90B USD
Enterprise Value1.31B USD
Revenue (TTM)98.34M USD
Gross Profit47.68M USD
Net Income (TTM)-412.78M USD
Revenue/Share1.68 USD
Last Price31.79 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees539
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-8.02
PEG—
EV/EBITDA-2.88
EV/Revenue13.29
P/S19.26
P/B1.84
EPS (TTM)-7.01
EPS (Forward)-3.96
52W Range
22.2440% of range46.00
52W High46.00 USD
52W Low22.24 USD
Profitability
Gross Margin88.26%
Oper. Margin-247.07%
EBITDA Margin0.00%
Profit Margin-764.01%
ROE-34.60%
ROA-31.82%
Growth
Revenue Growth259.30%
Earnings Growth—
Cash Flow & Leverage
Operating CF-372.98M USD
CapEx (TTM)14.32M USD
FCF Margin-279.25%
FCF Yield-14.47%
Net Debt-586.40M USD
Net Debt/EBITDA1.29
Balance Sheet
Debt/Equity0.03
Current Ratio10.22
Quick Ratio9.14
Book Value/Sh17.21 USD
Cash/Share10.34 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)46.25 USD
Upside (mean)+45.5%
Target Range32.00 USD – 73.00 USD
32.00+45.5% to mean73.00
# Analysts8
Ownership
Shares Out.59.70M
Float50.02M
Insiders1.07%
Institutions112.29%
Short Interest
Short Ratio8.8d
Short % Float12.79%
Short % Out.12.66%
Shares Short7.56M
Short (prev mo.)7.63M
Technical
SMA 5033.34 (-4.6%)
SMA 20031.04 (+2.4%)
Beta0.63
S&P 52W Chg16.45%
Avg Vol (30d)864.98K
Avg Vol (10d)1.09M
Technical Indicators
RSI (14)41.9
MACD-0.5305
MACD Signal-0.3503
MACD Hist.-0.1802
BB Upper35.06 USD
BB Middle33.11 USD
BB Lower31.15 USD
BB Width11.82%
ATR (14)1.322 USD
Vol Ratio (20d)1.74x